Characterization of 13 novel band 3 gene defects in hereditary spherocytosis with band 3 deficiency

Blood

Volumn 88, Issue 11, 1996, Pages 4366-4374

  Jarolim, Petr ^a   Murray, Jennifer L ^b   Rubin, Hillard L ^b   Taylor, William M ^b   Prchal, Josef T ^b   Ballas, Samir K ^b   Snyder, L Michael ^b   Chrobak, Ladislav ^b   Melrose, Wayne D ^b   Brabec, Vaclav ^b   Palek, Jiri ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ERYTHROCYTE BAND 3 PROTEIN; MESSENGER RNA;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FRAMESHIFT MUTATION; GENE MUTATION; HEREDITARY SPHEROCYTOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MISSENSE MUTATION; NONSENSE MUTATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RETICULOCYTE; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 10544253080     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.11.4366.bloodjournal88114366     Document Type: Article

References (60)

1. Dacie J: Hereditary spherocytosis (HS), in The Haemolytic Anaemias. Edinburgh, UK, Churchill Livingstone, 1985, p 134
2. Palek J, Jarolim P: Clinical expression and laboratory detection of red cell membrane protein mutations. Semin Hematol 30:249, 1993
3. Agre P, Orringer EP, Bennett V: Deficient red-cell spectrin in severe, recessively inherited spherocytosis. N Engl J Med 306:1155, 1982
4. Agre P, Casella JF, Zinkham WH, McMillan C, Bennett V: Partial deficiency of erythrocyte spectrin in hereditary spherocytosis. Nature 314:380, 1985
5. Savvides P, Shalev O, John KM, Lux SE: Combined spectrin and ankyrin deficiency is common in autosomal dominant hereditary spherocytosis. Blood 82:2953, 1993
6. Pekrun A, Eber SW, Kuhlmey A, Schroter W: Combined ankyrin and spectrin deficiency in hereditary spherocytosis. Ann Hematol 67:89, 1993
7. Jarolim P, Brabec V, Lambert S, Liu SC, Zhou Z, Palek J: Ankyrin Prague: A dominantly inherited mutation of the regulatory domain of ankyrin associated with hereditary spherocytosis. Blood 76:37a, 1990 (abstr, suppl 1)
8. Eber SW, Gonzalez JM, Lux ML, Scarpa AL, Tse WT, Dornwell M, Herbers J, Kugler W, Ozcan R, Pekrun A, Gallagher PG, Schroter W, Forget BG, Lux SE: Ankyrin-1 mutations are a major cause of dominant and recessive hereditary spherocytosis. Nat Genet 13:214, 1996
9. Jarolim P, Rubin HL, Brabec V, Palek J: A nonsense mutation 1669Glu → Ter within the regulatory domain of human erythroid ankyrin leads to a selective deficiency of the major ankyrin isoform (band 2.1) and a phenotype of autosomal dominant hereditary spherocytosis. J Clin Invest 94:941, 1995
10. Becker PS, Tse WT, Lux SE, Forget BG: β Spectrin Kissimmee - A spectrin variant associated with autosomal dominant hereditary spherocytosis and defective binding to protein 4.1. J Clin Invest 92:612, 1993
11. Wichterle H, Palek J, Hanspal M, Smockova Y, Brabec V, Jarolim P: Two recessively inherited defects of α spectrin underlie a severe, spectrin-deficient spherocytic hemolytic anemia. Blood 86:468a, 1995 (abstr, suppl 1)
12. Jarolim P, Ruff P, Coetzer TL, Prchal JT, Ballas SK, Poon M, Brabec V, Palek J: A subset of patients with dominantly inherited hereditary spherocytosis has a marked deficiency of the band 3 protein. Blood 76:37a, 1990 (abstr, suppl 1)
13. Lux SE, Bedrosian C, Shalev O, Morris M, Chasis J, Davies K, Savvides P, Telen M: Deficiency of band 3 in dominant hereditary spherocytosis with normal spectrin content. Clin Res 38:300A, 1990 (abstr)
14. Miraglia del Giudice E, Perrotta S, Pinto L, Cappellini MD, Fiorelli G, Cutillo S, Iolascon A: Hereditary spherocytosis characterized by increased spectrin/band-3 ratio. Br J Haematol 80:133, 1992
15. Iolascon A, Miraglia del Giudice E, Perrotta S, Pinto L, Fiorelli G, Cappelini DM, Vasseur C, Bursaux E, Cutillo S: Hereditary spherocytosis (HS) due to loss of anion exchange transporter. Haematologica 7:450, 1992
16. Reinhart WH, Wyss EJ, Arnold D, Ott P: Hereditary spherocytosis associated with protein band 3 defect in a Swiss kindred. Br J Haematol 86:147, 1994
17. Inoue T, Kanzaki A, Yawata A, Wada H, Okamoto N, Takahashi M, Sugihara T, Yamada O, Yawata Y: Uniquely higher incidence of isolated or combined deficiency of band 3 and/or band 4.2 as the pathogenesis of autosomal dominantly inherited spherocytosis in the Japanese population. Int J Hematol 60:227, 1994
18. Saad STO, Costa FF, Vicentim DL, Salles TSI, Pranke PHL: Red cell membrane protein abnormalities in hereditary spherocytosis in Brazil. Br J Haematol 88:295, 1994
19. Miraglia del Giudice E, Iolascon A, Pinto L, Nobili B, Perrotta S: Erythrocyte membrane protein alterations underlying clinical heterogeneity in hereditary spherocytosis. Br J Haematol 88:52, 1994
20. Jarolim P, Brabec V, Ballas SK, Prchal JT, Poon M, Castleberry R, Arnold D, Coetzer TL, Liu S, Palek J: Biochemical heterogeneity of the hereditary spherocytosis syndrome. Abstracts of the 24th Congress of the International Society of Haematology. South Bank Centre, London, UK, August 23-27, 1992, p 35 (abstr)
21. Ayala S, Besson I, Aymerich M, Berga L, Vives-Corrons JL: Abnormalities of red blood cell membrane proteins in hereditary spherocytosis and their relationship with clinical and biological aspects of the disease. Med Clin (Barc) 105:45, 1995
22. PRAGUE). J Clin Invest 93:121, 1994
23. Jarolim P, Rubin HL, Brabec V, Chrobak L, Zolotarev AS, Alper SL, Brugnara C, Wichterle H, Palek J: Mutations of conserved arginines in the membrane domain of erythroid band 3 protein lead to a decrease in membrane-associated band 3 and to the phenotype of hereditary spherocytosis. Blood 85:634, 1995
24. Maillet P, Valuer A, Reinhart WH, Wyss EJ, Ott P, Texier P, Baklouti F, Tanner MJA, Delaunay J, Alloisio N: Band 3 Chur: A variant associated with band 3-deficient hereditary spherocytosis and substitution in a highly conserved position of transmembrane segment 11. Br J Haematol 91:804, 1995
25. Jenkins PA, Abou-Alfa GK, Dhermy D, Bursaux E, Feo C, Scarpa AL, Lux SE, Garbarz M, Forget BG, Gallagher PG: A nonsense mutation in the erythrocyte band 3 gene associated with decreased mRNA accumulation in a kindred with dominant hereditary spherocytosis. J Clin Invest 97:373, 1996
26. Alloisio N, Texier P, Forissier A, Ribeiro ML, Morle L, Bozon M, Bursaux E, Maillet P, Tanner MJA, Tamagnini G, Delaunay J: Band 3 Coimbra: A variant associated with dominant hereditary spherocytosis and band 3 deficiency. Blood 82:4a, 1993 (abstr, suppl 1)
27. Miraglia del Giudice E, Alloisio N, Vallier A, Perrotta S, Cutillo S, Iolascon A, Delaunay J: Band 3 Foggia and band 3 Napoli: Frameshift mutations causing hereditary spherocytosis with band 3 deficiency. Blood 86:631a, 1995 (abstr, suppl 1)
28. Bianchi P, Zanella A, Alloisio N, Barosi G, Bredi E, Pelissero G, Zappa M, Vercellati C, Baronciani L, Delaunay J, Sirchia G: Band 3 Milano: A large (96 bp) duplication of the erythrocyte band 3 gene associated with dominant hereditary spherocytosis. Blood 86:468a, 1995 (abstr, suppl 1)
29. Sahr KE, Taylor WM, Daniels BP, Rubin HL, Jarolim P: The structure and organization of the human erythroid anion exchanger (AE1) gene. Genomics 24:491, 1994
30. Dodge JT, Mitchell C, Hanahan DJ: The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch Biochem Biophys 100:119, 1963
31. 327 substitution in the cytoplasmic domain of erythrocyte band 3 protein associated with spherocytic hemolytic anemia and partial deficiency of protein 4.2. Blood 80:523, 1992
32. Goosens M, Kan YW: DNA analysis in the diagnosis of hemoglobin disorders. Methods Enzymol 76:805, 1981
33. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T: Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 86:2766, 1989
34. Orita M, Suzuki Y, Sekiya T, Hayashi K: Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5:874, 1989
35. Tanner MJA, Martin PG, High S: The complete amino acid sequence of the human erythrocyte membrane anion-transport protein deduced from the cDNA. Biochem J 256:703, 1988
36. Lux SE, John KM, Kopito RR, Lodish HF: Cloning and characterization of band 3, the human erythrocyte anion-exchange protein (AE1). Proc Natl Acad Sci USA 86:9089, 1989
37. Kopito RR, Lodish HF: Structure of the murine anion exchange protein. J Cell Biochem 29:1, 1985
38. Kudrycki KE, Shull GE: Primary structure of the rat kidney band 3 anion exchange protein deduced from a cDNA. J Biol Chem 264:8185, 1989
39. Kim HRC, Yew NS, Ansorge W, Voss H, Schwager C. Vennström B, Zenke M, Engel JD: Two different mRNAs are transcribed from a single genomic locus encoding the chicken erythrocyte anion transport proteins (band 3). Mol Cell Biol 8:4416, 1988
40. Cox JV, Lazarides E: Alternative primary structures in the transmembrane domain of the chicken erythroid anionic transporter. Mol Cell Biol 8:1327, 1988
41. Hubner S, Michel F, Rudloff V, Appelhans H: Amino acid sequence of band-3 protein from rainbow trout erythrocytes derived from cDNA. Biochem J 285:17, 1992
42. Gehrig H, Muller W, Appelhans H: Complete nucleotide sequence of band 3 related anion transport protein AE2 from human kidney. Biochim Biophys Acta 1130:326, 1992
43. Alper SL, Kopito RR, Libresco SM, Lodish HM: Cloning and characterization of a murine band 3-related cDNA from kidney and from a lymphoid cell line. J Biol Chem 263:17092, 1988
44. Lindsey AE, Schneider K, Simmons DM, Baron R, Lee BS, Kopito RR: Functional expression and subcellular localization of an anion exchanger cloned from choroid plexus. Proc Natl Acad Sci USA 87:5278, 1990
45. - exchanger. J Biol Chem 265:462, 1990
46. Chow A, Dobbins JW, Aronson PS, Igarashi P: cDNA cloning and localization of a band 3-related protein from ileum. Am J Physiol 263:G345, 1992
47. Yannoukakos D, Stuart-Tilley A, Fernandez HA, Fey P, Duyk G, Alper SL: Molecular cloning, expression, and chromosomal localization of two isoforms of the AE3 anion exchanger from human heart. Circ Res 75:603, 1994
48. Kopito RR, Lee BS, Simmons DM, Lindsey AE, Morgans CW, Schneider K: Regulation of intracellular pH by a neuronal homolog of the erythrocyte anion exchanger. Cell 59:927, 1989
49. Montetiore). Blood 81:2155, 1993
50. Jarolim P, Rubin HL, Zhai S, Sahr KE, Liu SC, Mueller TJ, Palek J: Band 3 Memphis: A widespread polymorphism with abnormal electrophoretic mobility of erythrocyte band 3 protein caused by substitution AAG → GAG (Lys → Glu) in codon 56. Blood 80:1592, 1992
51. Jarolim P, Murray J, Rubin HL, Palek J: Molecular characterization of hereditary spherocytosis with band 3 deficiency. Blood 84:362a, 1994 (abstr, suppl 1)
52. Yannoukakos D, Stuart-Tilley A, Fernandez HA, Fey P, Duyk G, Alper SL: Molecular cloning, expression, and chromosomal localization of two isoforms of the AE3 anion exchanger from human heart. Circ Res 75:603, 1994
53. Jackson RJ: Cytoplasmic regulation of mRNA function: The importance of the 3′ untranslated region. Cell 74:9, 1994
54. n microsatellites in genomic DNA and mRNA reveals absence of one ankyrin mRNA allele in 20% of patients with hereditary spherocytosis. Blood 85:3278, 1995
55. Willardson BM, Thevenin BJM, Harrison ML, Kuster WM, Benson MD, Low PS: Localization of the ankyrin-binding site on erythrocyte membrane protein, band 3. J Biol Chem 264:15893, 1989
56. Davis L, Lux SE, Bennett V: Mapping the ankyrin-binding site of the human erythrocyte anion exchanger. J Biol Chem 264:9665, 1989
57. Gomez S, Morgans C: Interaction between band 3 and ankyrin begins in early compartments of the secretory pathway and is essential for band 3 processing. J Biol Chem 268:19593, 1993
58. Romans AY, Yeagle PL, O'Connor SE, Grisham CM: Interaction between glycophorin and phospholipids in recombined systems. J Supramol Structure 10:241, 1979
59. Lux SE, Palek J: Disorders of the red cell membrane, in Handin RI, Lux SE, Stossel TP (eds): Blood: Principles and Practice of Hematology. Philadelphia, PA, Lippincott, 1995, p 1701
60. Peters LL, Shivdasani RA, Liu S, John KM, Brugnara C, Gwynn B, Kirley LA, Orkin SH, Lux SE: Targeted disruption of the band 3 gene in mice causes severe hemolytic anemia despite a nearly normal membrane skeleton assembly. Blood 86:124a, 1995 (abstr, suppl 1)